Cardiol Therapeutics Inc. (TSX: CRDL)
Canada
· Delayed Price · Currency is CAD 2.260
+0.040 (1.80%)
Nov 22, 2024, 4:00 PM EST
Cardiol Therapeutics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
184.42M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bausch + Lomb Corporation | 6.33B |
| Bausch Health Companies Inc. | 12.80B |
| Curaleaf Holdings, Inc. | 1.83B |
| dentalcorp Holdings Ltd. | 1.51B |
| Tilray Brands, Inc. | 1.10B |
| Sienna Senior Living Inc. | 867.55M |
| WELL Health Technologies Corp. | 957.69M |
| Cronos Group Inc. | 150.26M |
Cardiol Therapeutics News
- 5 days ago - CBD-Based Drug Reduces Pericarditis Pain And Inflammation, Shows New Clinical Study - Benzinga
- 6 days ago - Cardiol Therapeutics' Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024 - Newsfile Corp
- 11 days ago - Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index - GlobeNewsWire
- 4 weeks ago - IRW-News: Cardiol Therapeutics Inc. : Cardiol Therapeutics will CardiolRx in eine Studie der späten Phase an Patienten mit rezidivierender Perikarditis überführen - Onvista
- 4 weeks ago - Cardiol Therapeutics to Advance CardiolRx(TM) into a Late-Stage Trial in Patients with Recurrent Pericarditis - Newsfile Corp
- 6 weeks ago - Cardiol Therapeutics Announces Exercise and Closing of Over-Allotment Option - Newsfile Corp
- 6 weeks ago - Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares - Newsfile Corp
- 6 weeks ago - Why Cardiol Therapeutics (CRDL) Stock Is Down 20% Today - Benzinga